NCT02929095View on ClinicalTrials.gov

The Effect of Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam on Patient's Satisfaction

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

April 2, 2018

Study Completion Date

April 2, 2018

Conditions
Peripheral Arterial Occlusive Disease
Interventions
DRUG

dexmedetomidine

DRUG

midazolam

DRUG

remifentanil

\- remifentanil will be administered to both dexmedetomidine and midazolam group as a routine part of procedure and it is no of interest of the protocol

Trial Locations (1)

03722

Department of Anaesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02929095 - The Effect of Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam on Patient's Satisfaction | Biotech Hunter | Biotech Hunter